Development of Natural-Based Bone Cement for a Controlled Doxorubicin-Drug Release

Osteosarcoma (OS) accounts for 60% of all global bone cancer diagnoses. Intravenous administration of Doxorubicin Hydrochloride (DOXO) is the current form of OS treatment, however, systemic delivery has been linked to the onset of DOXO induced cardiomyopathy. Biomaterials including calcium phosphate...

Descripción completa

Detalles Bibliográficos
Autores principales: Dewhurst, Rebecca Marie, Scalzone, Annachiara, Buckley, Joseph, Mattu, Clara, Rankin, Kenneth S., Gentile, Piergiorgio, Ferreira, Ana Marina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Bioengineering and Biotechnology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7363953/
https://www.ncbi.nlm.nih.gov/pubmed/32733869
http://dx.doi.org/10.3389/fbioe.2020.00754

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7363953/
https://www.ncbi.nlm.nih.gov/pubmed/32733869
http://dx.doi.org/10.3389/fbioe.2020.00754

Ejemplares similares